BIT 0.00% 3.3¢ biotron limited

$10 Billion Deal, page-5724

  1. 229 Posts.
    lightbulb Created with Sketch. 355
    From memory (not certain) I think it was Gilead having patent run out in 2023 with HIV, which was one of the reasons they diversified with purchase of Forty Seven.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.